120 West Pomona Avenue
Monrovia, CA 91016
United States
626-538-4779
https://www.immunotechlab.com
Sector(s):
Industry:
Full Time Employees: 4
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Harry H. Zhabilov Jr. | Founder, Vice Chairman, President, Chief Science Officer & Secretary | N/A | N/A | 1967 |
Billy Ray | CFO, Executive of Business and Development & Member of Advisory Board | N/A | N/A | N/A |
Mr. Adam S. Tracy Esq., J.D., MBA | Legal Counsel | N/A | N/A | 1976 |
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Eco-Petroleum Solutions, Inc.
Immunotech Laboratories, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.